CWBHF Overview

Appointment Announcement: Charlotte's Web Holdings, Inc. has appointed M. Borgia Walker to its Board of Directors, effective November 1, 2025, bringing extensive experience in transformation and financial leadership from the consumer goods and financial services sectors.

Professional Background: Ms. Walker currently serves as Chief People Officer at Reynolds American Inc. and has a strong background in human resources, finance, compliance, and strategic transformation, with a career spanning over 30 years.

Community Involvement: In addition to her corporate roles, Ms. Walker is committed to community service, having served on various boards, including Allegacy Federal Credit Union and the YWCA, and has received multiple awards for her contributions to business and community.

Company Vision: Charlotte's Web emphasizes the importance of Ms. Walker's expertise in navigating regulatory environments and her commitment to sustainability, aligning with the company's values as a Certified B Corporation.

New Sleep Support Product: Charlotte's Web has launched Quiet Sleep Mushroom Gummies, a melatonin-free and cannabinoid-free sleep aid made with reishi mushroom, chamomile, and magnesium to promote relaxation and quality sleep.

Market Demand and Trends: The product addresses the growing consumer interest in natural sleep solutions, as a survey indicates that 43% of Americans struggle with sleep due to racing thoughts, highlighting a trend towards functional mushroom and botanical wellness.

Formation of Scientific Advisory Board: Charlotte's Web Holdings, Inc. has established a Scientific Advisory Board to enhance its medical strategy and promote science-backed innovation, focusing on patient-centered solutions starting September 2025.

Research and Development Initiatives: The board, led by Dr. Marcel Bonn-Miller, will oversee research, clinical initiatives, and product development, including the advancement of AJA001, a CBD extract cleared for Phase 2 trials for treating irritability in autism spectrum disorder.

Formation of Scientific Advisory Board: Charlotte's Web Holdings, Inc. is establishing a Scientific Advisory Board to enhance its medical strategy and support research and development initiatives, set to begin in September 2025.

Focus on Clinical Relevance and Education: The board will guide product formulations and practitioner education, aiming to address patient care gaps by providing clinically relevant CBD solutions and creating Continuing Medical Education (CME) content for healthcare professionals.

Appointment of New CFO: Aclarion, Inc. has appointed Greg Gould as Chief Financial Officer, succeeding John Lorbiecki, who is retiring. Gould brings over 30 years of experience in public and private companies, focusing on growth and shareholder value.

Company's Focus and Technology: Aclarion is a healthcare technology firm that utilizes biomarkers and AI algorithms to assist physicians in identifying chronic low back pain. Their Nociscan platform is the first evidence-supported SaaS solution designed to differentiate between painful and nonpainful lumbar discs.

Annual Meeting Results: Charlotte's Web Holdings, Inc. held its 2025 annual general meeting on June 12, where 58,493,957 votes were cast, representing 36.87% of total voting shares, with various directors elected receiving between 66% to 87% approval.

Company Overview: Charlotte's Web is a leading botanical wellness company specializing in hemp extract products, including CBD oils, gummies, and pet products, emphasizing quality control through a vertically integrated business model.